| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c7401c5a4678ae7107cb19df7740c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_939e553e62fdcaf6ca4ec9eb2603d676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbbc4b62c6e26bf980ec69ab1b0cf0aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9084a9c8618bca77c40b0122ea2395e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-822 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 |
| filingDate |
2010-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_900cc42ce201e623ecc367201aabe66e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de5dfa67acd3037d61327c6394e49394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62561c8575281e49d4b36f1ca66a740a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edf684477cd1f39eb2abe1faab72ec69 |
| publicationDate |
2016-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9492437-B2 |
| titleOfInvention |
Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients |
| abstract |
The invention relates to the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in non-ST elevation myocardial infarction, said treatment comprising administering a therapeutically effective amount of (2R,3R)-2-(3-Carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof to a human patient, who is elderly and/or shows renal insufficiency and/or has a low body weight. |
| priorityDate |
2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |